The Brugada ECG pattern a marker of channelopathy, structural heart disease, or neither? Toward a unifying mechanism of the Brugada syndrome

Circulation: Arrhythmia and Electrophysiology

Volumn 3, Issue 3, 2010, Pages 283-290

  Hoogendijk, Mark G ^a   Opthof, Tobias ^a   Postema, Pieter G ^a   Wilde, Arthur A M ^a   De Bakker, Jacques M T ^a,b   Coronel, Ruben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

Arrhythmia; Brugada syndrome; Sodium channel; ST segment elevation; Structure

Indexed keywords

CALCIUM CHANNEL L TYPE; SODIUM CHANNEL; SODIUM CHANNEL NAV1.5; ION CHANNEL;

BRUGADA SYNDROME; CHAGAS DISEASE; CHANNELOPATHY; CLINICAL FEATURE; ELECTROCARDIOGRAM; GENE MUTATION; HEART DISEASE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HISTOPATHOLOGY; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QRS COMPLEX; QT PROLONGATION; REVIEW; ANIMAL; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MUTATION; PREDICTION AND FORECASTING; RISK FACTOR;

ANIMALS; BRUGADA SYNDROME; ELECTROCARDIOGRAM PATTERN; GENETIC PREDISPOSITION TO DISEASE; HEART DISEASES; HUMANS; ION CHANNELS; MUTATION; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 77954674875     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.110.937029     Document Type: Review

References (88)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol. 1992;20: 1391-1396.
2. Nademanee K, Veerakul G, Nimmannit S, Chaowakul V, Bhuripanyo K, Likittanasombat K, Tunsanga K, Kuasirikul S, Malasit P, Tansupasawadikul S, Tatsanavivat P. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation. 1997;96: 2595-2600.
3. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation. 2005;111: 659-670.
4. Sacher F, Probst V, Iesaka Y, Jacon P, Laborderie J, Mizon-Gerard F, Mabo P, Reuter S, Lamaison D, Takahashi Y, O'Neill MD, Garrigue S, Pierre B, Jais P, Pasquie JL, Hocini M, Salvador-Mazenq M, Nogami A, Amiel A, Defaye P, Bordachar P, Boveda S, Maury P, Klug D, Babuty D, Haissaguerre M, Mansourati J, Clementy J, Le Marec H. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Circulation. 2006;114:2317-2324.
5. Meregalli PG, Wilde AAM, Tan HL. Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more? Cardiovasc Res. 2005;67:367-378.
6. Keating M, Atkinson D, Dunn C, Timothy K, Vincent GM, Leppert M. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science. 1991;252:704-706.
7. Goldenberg I, Moss AJ. Long QT Syndrome. J Am Coll Cardiol. 2008; 51:2291-2300.
8. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, Potenza D, Moya A, Borggrefe M, Breithardt G, Ortiz-Lopez R, Wang Z, Antzelevitch C, O'Brien RE, Schulze-Bahr E, Keating MT, Towbin JA, Wang Q. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature. 1998;392:293-296.
9. Priori SG, Napolitano C, Gasparini M, Pappone C, Bella PD, Giordano U, Bloise R, Giustetto C, De Nardis R, Grillo M, Ronchetti E, Faggiano G, Nastoli J. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation. 2002;105:1342-1347. (Pubitemid 34260426)
10. Schulze-Bahr E, Eckardt L, Breithardt G, Seidl K, Wichter T, Wichter T, Borggrefe M, Haverkamp W. Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease. Hum Mutat. 2009;21:651-652.
11. + current and causes inherited arrhythmias. Circulation. 2007;116:2260-2268.
12. Watanabe H, Koopmann TT, Le Scouarnec S, Yang T, Ingram CR, Schott J, Demolombe S, Probst V, Anselme F, Escande D, Wiesfeld A, Pfeurer A, Kaab S, Wichmann H, Hasdemir C, Aizawa Y, Wilde AAM, Roden D, Bezzina C. Sodium channel ß1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest. 2008;118:2260-2268.
13. Hu D, Barajas-Martinez H, Burashnikov E, Springer M, Wu Y, Varro A, Pfeiffer R, Koopmann TT, Cordeiro J, Guerchicoff A, Pollevick G, Antzelevitch C. A mutation in the β3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype. Circ Cardiovasc Genet. 2009;3:270-278.
14. Koopmann TT, Beekman L, Alders M, Meregalli PG, Mannens MMAM, Moorman AFM, Wilde AAM, Bezzina CR. Exclusion of multiple candidate genes and large genomic rearrangements in SCN5A in a Dutch Brugada syndrome cohort. Heart Rhythm. 2007;4:752-755.
15. Makiyama T, Akao M, Haruna Y, Tsuji K, Doi T, Ohno S, Nishio Y, Kita T, Horie M. Mutation analysis of the glycerol-3 phosphate dehydrogenase-1 like (GPD1L) gene in Japanese patients with Brugada syndrome. Circ J. 2008;72:1705-1706.
16. Delpon E, Cordeiro J, Nunez L, Thomsen P, Guerchicoff A, Pollevick G, Wu Y, Kanters J, Larsen C, Burashnikov E, Christiansen M, Antzelevitch C. Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythmia Electrophysiol. 2009;1:209-218.
17. Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, Aizawa Y, Guerchicoff A, Pfeiffer R, Oliva A, Wollnik B, Gelber P, Bonaros EP Jr, Burashnikov E, Wu Y, Sargent JD, Schickel S, Oberheiden R, Bhatia A, Hsu LF, Haissaguerre M, Schimpf R, Borggrefe M, Wolpert C. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation. 2007;115: 442-449.
18. Brugada J, Brugada P. Further characterization of the syndrome of right bundle branch block, ST segment elevation, and sudden cardiac death. J Cardiovasc Electrophysiol. 1997;8:325-331.
19. Kasanuki H, Ohnishi S, Ohtuka M, Matsuda N, Nirei T, Isogai R, Shoda M, Toyoshima Y, Hosoda S. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation. 1997;95:2277-2285.
20. Morita H, Nagase S, Miura D, Miura A, Hiramatsu S, Tada T, Murakami M, Nishii N, Nakamura K, Morita ST, Oka T, Kusano KF, Ohe T. Differential effects of cardiac sodium channel mutations on initiation of ventricular arrhythmias in patients with Brugada syndrome. Heart Rhythm. 2009;6:487-492.
21. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AAM, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R. Genotype- phenotype correlation in the long-QT syndrome: Gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103:89-95.
22. Mizumaki K, Fujiki A, Tsuneda T, Sakabe M, Nishida K, Sugao M, Inoue H. Vagal activity modulates spontaneous augmentation of ST elevation in the daily life of patients with Brugada syndrome. J Cardiovasc Electrophysiol. 2004;15:667-673.
23. Ikeda T, Abe A, Yusu S, Nakamura K, Ishiguro H, Mera H, Yotsukura M, Yoshino H. The full stomach test as a novel diagnostic technique for identifying patients at risk of Brugada syndrome. J Cardiovasc Electrophysiol. 2006;17:602-607.
24. Matsuo K, Kurita T, Inagaki M, Kakishita M, Aihara N, Shimizu W, Taguchi A, Suyama K, Kamakura S, Shimomura K. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. Eur Heart J. 1999;20:465-470.
25. Wichter T, Matheja P, Eckardt L, Kies P, Schäfers K, Schulze-Bahr E, Haverkamp W, Borggrefe M, Schober O, Breithardt G, Schäfers M. Cardiac autonomic dysfunction in Brugada syndrome. Circulation. 2002; 105:702-706.
26. Amin AS, Meregalli PG, Bardai A, Wilde AAM, Tan HL. Fever increases the risk for cardiac arrest in the Brugada syndrome. Ann Intern Med. 2008;149:216-218.
27. Tan HL, Meregalli PG. Lethal ECG changes hidden by therapeutic hypothermia. Lancet. 2007;369:78.
28. Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Ogawa S, Aizawa Y. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol. 1996;27: 1061-1070.
29. Alings M, Dekker LRC, Sadee A, Wilde AAM. Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome. Pacing Clin Electrophysiol. 2001;24:1420-1422.
30. Belhassen B, Viskin S, Fish R, Glick A, Setbon I, Eldar M. Effects of electrophysiologic-guided therapy with class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome. J Cardiovasc Electrophysiol. 1999;10:1301-1312.
31. Stanton MS. Class 1 antiarrhythmic drugs: quinidine, procainamide, disopyramide, lidocaine, mexiletine, tocainide, phenytoin, morcizine, flecainide, propafenone. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, PA: WB Saunders Company; 2000:890-903.
32. Tanaka H, Kinoshita O, Uchikawa S, Kasai H, Nakamura M, Izawa A, Yokoseki O, Kitabayashi H, Takahashi W, Yazaki Y, Watanabe N, Imamura H, Kubo K. Successful prevention of recurrent ventricular fibrillation by intravenous isoproterenol in a patient with Brugada syndrome. Pacing Clin Electrophysiol. 2001;24:1293-1294.
33. Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation. 1999;100:1660-1666.
34. Näbauer M, Beuckelmann DJ, Ü berfuhr P, Steinbeck G. Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation. 1996;93:168-177.
35. Coronel R, Berecki G, Opthof T. Why the Brugada syndrome is not yet a disease: syndromes, diseases, and genetic causality. Cardiovasc Res. 2006;72:361-363.
36. Sakabe M, Fujiki A, Tsuneda T, Nishida K, Sugao M, Mizumaki K, Inoue H. Brugada syndrome occurring in an identical twin: a case report. J Cardiol. 2002;40:111-115.
37. + channel mutation causing both Long-QT and Brugada syndromes. Circ Res. 1999;85:1206-1213.
38. Probst V, Wilde AAM, Barc J, Sacher F, Babuty D, Mabo P, Mansourati J, Le Scouarnec S, Kyndt F, Le Caignec C, Guicheney P, Gouas L, Albuisson J, Meregalli PG, Le Marec H, Tan HL, Schott JJ. SCN5A Mutations and the role of genetic background in the pathophysiology of Brugada syndrome. Circ Cardiovasc Genet. 2009;2:552-557.
39. Nagase S, Kusano KF, Morita H, Nishii N, Banba K, Watanabe A, Hiramatsu S, Nakamura K, Sakuragi S, Ohe T. Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome. J Am Coll Cardiol. 2008;51:1154-1161.
40. Shimizu W, Aiba T, Kurita T, Kamakura S. Paradoxic abbreviation of repolarization in epicardium of the right ventricular outflow tract during augmentation of Brugada-type ST segment elevation. J Cardiovasc Electrophysiol. 2001;12:1418-1421.
41. Kurita T, Shimizu W, Inagaki M, Suyama K, Taguchi A, Satomi K, Aihara N, Kamakura S, Kobayashi J, Kosakai Y. The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome. J Am Coll Cardiol. 2002;40:330-334.
42. Coronel R, Casini S, Koopmann TT, Wilms-Schopman FJG, Verkerk AO, de Groot JR, Bhuiyan Z, Bezzina CR, Veldkamp MW, Linnenbank AC, van der Wal AC, Tan HL, Brugada P, Wilde AAM, de Bakker JMT. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation. 2005;112: 2769-2777.
43. Kyndt F, Probst V, Potet F, Demolombe S, Chevallier JC, Baro I, Moisan JP, Boisseau P, Schott JJ, Escande D, Le Marec H. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation. 2001;104:3081-3086.
44. Martini B, Nava A, Thiene G, Buja GF, Canciani B, Scognamiglio R, Daliento L, la Volta S. Ventricular fibrillation without apparent heart disease: Description of six cases. Am Heart J. 1989;118:1203-1209.
45. Martini B, Cannas S, Nava A. Brugada by any other name? Eur Heart J. 2001;22:1835-1836.
46. Corrado D, Basso C, Buja G, Nava A, Rossi L, Thiene G. Right bundle branch block, right precordial ST-segment elevation, and sudden death in young people. Circulation. 2001;103:710-717.
47. Kirschner RH, Eckner FAO, Baron RC. The cardiac pathology of sudden, unexplained nocturnal death in Southeast Asian refugees. JAMA. 1986; 256:2700-2705.
48. Corrado D, Nava A, Buja G, Martini B, Fasoli G, Oselladore L, Turrini P, Thiene G. Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. J Am Coll Cardiol. 1996;27:443-448. (Pubitemid 26045511)
49. Tada H, Aihara N, Ohe T, Yutani C, Hamada S, Miyanuma H, Takamiya M, Kamakura S. Arrhythmogenic right ventricular cardiomyopathy underlies syndrome of right bundle branch block, ST-segment elevation, and sudden death. Am J Cardiol. 1998;81:519-522.
50. Remme CA, Wever EFD, Wilde AAM, Derksen R, Hauer RNW. Diagnosis and long-term follow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation. Eur Heart J. 2001;22:400-409.
51. Zumhagen S, Spieker T, Rolinck J, Baba HA, Breithardt G, Bocker W, Eckardt L, Paul M, Wichter T, Schulze-Bahr E. Absence of pathognomonic or inflammatory patterns in cardiac biopsies from patients with Brugada syndrome. Circ Arrhythm Electrophysiol. 2009;2:16-23.
52. Frustaci A, Priori SG, Pieroni M, Chimenti C, Napolitano C, Rivolta I, Sanna T, Bellocci F, Russo MA. Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation. 2005;112: 3680-3687. (Pubitemid 43739507)
53. Takagi M, Aihara N, Kuribayashi S, Taguchi A, Shimizu W, Kurita T, Suyama K, Kamakura S, Hamada S, Takamiya M. Localized right ventricular morphological abnormalities detected by electron-beam computed tomography represent arrhythmogenic substrates in patients with the Brugada syndrome. Eur Heart J. 2001;22:1032-1041.
54. Papavassiliu T, Wolpert C, FlÜchter S, Schimpf R, Neff W, Haase KK, DÜber C, Borggrefe M. Magnetic resonance imaging findings in patients with Brugada syndrome. J Cardiovasc Electrophysiol. 2004;15: 1133-1138.
55. Catalano O, Antonaci S, Moro G, Mussida M, Frascaroli M, Baldi M, Cobelli F, Baiardi P, Nastoli J, Bloise R, Monteforte N, Napolitano C, Priori SG. Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities. Eur Heart J. 2009;30: 2241-2248.
56. Tukkie R, Sogaard P, Vleugels J, de Groot IKLM, Wilde AAM, Tan HL. Delay in right ventricular activation contributes to Brugada syndrome. Circulation. 2004;109:1272-1277.
57. Ikeda T, Sakurada H, Sakabe K, Sakata T, Takami M, Tezuka N, Nakae T, Noro M, Enjoji Y, Tejima T, Sugi K, Yamaguchi T. Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification. J Am Coll Cardiol. 2001;37: 1628-1634.
58. Berbari EJ, Scherlag BJ, Hope RR, Lazzara R. Recording from the body surface of arrhythmogenic ventricular activity during the S-T segment. Am J Cardiol. 1978;41:697-702.
59. Blomstrom-Lundqvist C, Hirsch I, Olsson SB, Edvardsson N. Quantitative analysis of the signal-averaged QRS in patients with arrhythmogenic right ventricular dysplasia. Eur Heart J. 1988;9:301-312.
60. Nagase S, Kusano KF, Morita H, Fujimoto Y, Kakishita M, Nakamura K, Emori T, Matsubara H, Ohe T. Epicardial electrogram of the right ventricular outflow tract in patients with the Brugada syndrome: Using the epicardial lead. J Am Coll Cardiol. 2002;39:1992-1995.
61. Morita H, Kusano KF, Miura D, Nagase S, Nakamura K, Morita ST, Ohe T, Zipes DP, Wu J. Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome. Circulation. 2008;118:1697-1704.
62. Das MK, Khan B, Jacob S, Kumar A, Mahenthiran J. Significance of a fragmented QRS complex versus a Q wave in patients with coronary artery disease. Circulation. 2006;113:2495-2501.
63. Peters S, TrÜmmel M, Koehler B. QRS fragmentation in standard ECG as a diagnostic marker of arrhythmogenic right ventricular dysplasia- cardiomyopathy. Heart Rhythm. 2008;5:1417-1421.
64. Lambiase PD, Ahmed AK, Ciaccio EJ, Brugada R, Lizotte E, Chaubey S, Ben-Simon R, Chow AW, Lowe MD, McKenna WJ. High-density substrate mapping in Brugada syndrome: combined role of conduction and repolarization heterogeneities in arrhythmogenesis. Circulation. 2009; 120:106-117.
65. Postema PG, van Dessel PFHM, de Bakker JMT, Dekker LRC, Linnenbank AC, Hoogendijk MG, Coronel R, Tijssen JGP, Wilde AAM, Tan HL. Slow and discontinuous conduction conspire in Brugada syndrome: a right ventricular mapping and stimulation study. Circ Arrhythm Electrophysiol. 2008;1:379-386.
66. Kawara T, Derksen R, de Groot JR, Coronel R, Tasseron S, Linnenbank AC, Hauer RNW, Kirkels H, Janse MJ, de Bakker JMT. Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Circulation. 2001;104: 3069-3075.
67. Chiale PA, Przybylski J, Lainõ RA, Halpern MS, Sánchez RA, Gabrieli A, Elizari MV, Rosenbaum MB. Electrocardiographic changes evoked by ajmaline in chronic Chagas' disease without manifest myocarditis. Am J Cardiol. 1982;49:14-20.
68. Peters S, TrÜmmel M, Denecke S, Koehler B. Results of ajmaline testing in patients with arrhythmogenic right ventricular dysplasia- cardiomyopathy. Int J Cardiol. 2004;95:207-210.
69. Hoogendijk MG, Potse M, Linnenbank AC, Verkerk AO, Den Ruijter HM, van Amersfoorth SC, Klaver EC, Beekman L, Bezzina CR, Postema PG, Tan HL, Reimer AG, van der Wal AC, ten Harkel ADJ, Dalinghaus M, Vinet A, Wilde AAM, de Bakker JMT, Coronel R. Mechanism of right precordial ST-segment elevation in structural heart disease: Excitation failure by current-to-load mismatch. Heart rhythm. 2010;7: 238-248.
70. Cabo C, Pertsov AM, Baxter WT, Davidenko JM, Gray RA, Jalife J. Wave-front curvature as a cause of slow conduction and block in isolated cardiac muscle. Circ Res. 1994;75:1014-1028.
71. Rohr S, Kucera JP. Involvement of the calcium inward current in cardiac impulse propagation: induction of unidirectional conduction block by nifedipine and reversal by Bay K 8644. Biophys J. 1997;72:754-766.
72. Joyner RW, Kumar R, Wilders R, Jongsma HJ, Verheijck EE, Golod DA, van Ginneken ACG, Wagner MB, Goolsby WN. Modulating L-type calcium current affects discontinuous cardiac action potential conduction. Biophys J. 1996;71:237-245.
73. Huelsing DJ, Spitzer KW, Cordeiro JM, Pollard AE. Conduction between isolated rabbit Purkinje and ventricular myocytes coupled by a variable resistance. Am J Physiol Heart Circ Physiol. 1998;274:H1163-H1173.
74. Watanabe H, Chinushi M, Osaki A, Okamura K, Izumi D, Komura S, Hosaka Y, Tanabe Y, Furushima H, Washizuka T, Aizawa Y. Elimination of late potentials by quinidine in a patient with Brugada syndrome. J Electrocardiol. 2006;39:63-66.
75. Elizari MV, Levi RL, Acunzo RS, Chiale PA, Civetta MM, Ferreiro M, Sicouri S. Abnormal expression of cardiac neural crest cells in heart development: a different hypothesis for the etiopathogenesis of Brugada syndrome. Heart Rhythm. 2007;4:359-365.
76. Boukens BJD, Christoffels VM, Coronel R, Moorman AFM. Developmental basis for electrophysiological heterogeneity in the ventricular and outflow tract myocardium as a substrate for life-threatening ventricular arrhythmias. Circ Res. 2009;104:19-31.
77. Oken D, Boucek R. Quantitation of collagen in human myocardium. Circ Res. 1957;5:357-361.
78. Tansey DK, Aly Z, Sheppard MN. Fat in the right ventricle of the normal heart. Histopathology. 2005;46:98-104.
79. Veeraraghavan R, Poelzing S. Mechanisms underlying increased right ventricular conduction sensitivity to flecainide challenge. Cardiovasc Res. 2008;77:749-756.
80. Remme C, Verkerk A, Hoogaars W, Aanhaanen W, Scicluna B, Annink C, van den Hoff M, Wilde A, van Veen T, Veldkamp M, de Bakker J, Christoffels V, Bezzina C. The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium. Basic Res Cardiol. 2009;104: 511-522.
81. Durrer D, van Dam R, Freud G, Janse M, Meijler F, Arzbaecher R. Total excitation of the isolated human heart. Circulation. 1970;41:899-912.
82. Oe H, Takagi M, Tanaka A, Namba M, Nishibori Y, Nishida Y, Kawarabayashi T, Yoshiyama M, Nishimoto M, Tanaka K, Yoshikawa J. Prevalence and clinical course of the juveniles with Brugada-type ECG in Japanese population. Pacing Clin Electrophysiol. 2005;28:549-554.
83. Probst V, Denjoy I, Meregalli PG, Amirault JC, Sacher F, Mansourati J, Babuty D, Villain E, Victor J, Schott JJ, Lupoglazoff JM, Mabo P, Veltmann C, Jesel L, Chevalier P, Clur SA, Haissaguerre M, Wolpert C, Le Marec H, Wilde AAM. Clinical aspects and prognosis of Brugada syndrome in children. Circulation. 2007;115:2042-2048.
84. Fontaine G, Anouate P, Fontaliran F. Repolarization and the genesis of cardiac arrhythmias: role of body surface mapping. Circulation. 1997;95: 2600-2602.
85. Royer A, van Veen TAB, Le Bouter S, Marionneau C, Griol-Charhbili V, Leoni AL, Steenman M, van Rijen HVM, Demolombe S, Goddard CA, Richer C, Escoubet B, Jarry-Guichard T, Colledge WH, Gros D, de Bakker JMT, Grace AA, Escande D, Charpentier F. Mouse model of SCN5A-linked hereditary Lenegre's disease: age-related conduction slowing and myocardial fibrosis. Circulation. 2005;111:1738-1746.
86. Case MT, Sibinski LJ, Steffen GR. Chronic oral toxicity and oncogenicity studies of flecainide, an antiarrhythmic, in rats and mice. Toxicol Appl Pharmacol. 1984;73:232-242.
87. Sato PY, Musa H, Coombs W, Guerrero-Serna G, Patino GA, Taffet SM, Isom LL, Delmar M. Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes. Circ Res. 2009;105:523-526.
88. Gerull B, Heuser A, Wichter T, Paul M, Basson CT, McDermott DA, Lerman BB, Markowitz SM, Ellinor PT, MacRae CA, Peters S, Grossmann KS, Michely B, Sasse-Klaassen S, Birchmeier W, Dietz R, Breithardt G, Schulze-Bahr E, Thierfelder L. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet. 2004;36:1162-1164.